{
    "2018-07-27": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Antibiotics market wipes out 80 jobs at Peninsula company a month after its 1st drug approval",
                "features": {
                    "keywords": [
                        "Antibiotics",
                        "market",
                        "jobs",
                        "drug",
                        "approval"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "1 week until the deadline for Disrupt SF 2018â€™s Hackathon + new sponsor prizes",
                "features": {
                    "keywords": [
                        "Disrupt",
                        "SF",
                        "Hackathon",
                        "sponsor",
                        "prizes"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-08-03",
                "original_text": "Roche (RHHBY) 1H18 Revenues Up Y/Y on Solid New Drug Sales",
                "features": {
                    "keywords": [
                        "Roche",
                        "Revenues",
                        "Up",
                        "Drug",
                        "Sales"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "Amgen (AMGN) Q2 Earnings & Sales Beat Estimates, View Up",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Q2",
                        "Earnings",
                        "Sales",
                        "Beat",
                        "Estimates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Incyte (INCY) to Report Q2 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Q2",
                        "Earnings"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-27",
                "original_text": "The Swiss Stock Market Logged Modest Gains - LafargeHolcim In Focus",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Gains",
                        "LafargeHolcim"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-28",
                "original_text": "The Swiss Stock Market",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "Novartis' Sandoz Gets European Commission Approval For Biosimilar Hyrimoz",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Sandoz",
                        "European",
                        "Commission",
                        "Approval",
                        "Biosimilar",
                        "Hyrimoz"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-13",
                "original_text": "Novartis: Tafinlar + Mekinist Combination Gets Positive CHMP Opinion",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Tafinlar",
                        "Mekinist",
                        "Combination",
                        "CHMP",
                        "Opinion"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}